A pan-Canadian research team led by Dr. Helen McTaggart-Cowan, a BC Cancer scientist, will receive $183,500 through a new Patient Voices in Research Initiative from the Terry Fox Research Institute’s Marathon of Hope Cancer Centres Network (the Network) to examine barriers to accessing homologous recombination deficiency (HRD) testing for patients with advanced ovarian cancer.
Congratulations to Dr. Laura Evgin for being selected as one of the 2025 Canada Gairdner Early Career Investigators for her work in CAR T-cell therapy.
Dr. Nadine Caron has been inducted into the Canadian Medical Hall of Fame in recognition of her transformative leadership in Indigenous health and surgical practice.
Dr. Caron is a senior scientist with BC Cancer’s Genome Sciences Centre, co-director of the UBC Centre for Excellence in Indigenous Health and a professor in UBC’s department of surgery and Northern Medical Program, which is delivered in partnership with the University of Northern British Columbia.
Congratulations to the recipients of the BC Cancer Foundation (BCCF) 2024 Rising Stars Award competition!
This year’s awardees are:
BC Cancer researchers receive Cancer Research Society’s Doctoral Research Awards
Three BC Cancer graduate students are 2024 recipients of Doctoral Research Awards from the Cancer Research Society (CRS), receiving new funding to support their innovative research aimed at better understanding cancer.
Doctoral Research Awards recipients
BC Cancer’s 2024 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.
2024 Emerging Multidisciplinary Research Programs Recipients:
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.